StrainsforPains, Inc. (EBYH)
| Market Cap | 2.10M +64.4% |
| Revenue (ttm) | n/a |
| Net Income | -102.80K |
| EPS | -0.23 |
| Shares Out | 12.92M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 401 |
| Average Volume | 1,329 |
| Open | 0.1605 |
| Previous Close | 0.1626 |
| Day's Range | 0.1605 - 0.1626 |
| 52-Week Range | 0.1605 - 0.1900 |
| Beta | -0.04 |
| RSI | 44.91 |
| Earnings Date | n/a |
About StrainsforPains
StrainsforPains, Inc. operates as a health and wellness company that specializes in data technology that develops and sells CBD/THC products. The company empowers healthcare providers, patients, and dispensaries with access to an AI search engine app enabling users to compare various cannabis strains or brands and assess their effectiveness in treating illnesses, chronic conditions, and dietary needs. Its product line covers pain related to muscle, migraines, arthritis, menstrual, sleep, and digestive disorders. The company collaborate with hos... [Read more]
Financial Performance
Financial StatementsNews
Strainsforpains EBYH (OTC: EBYH), Collaborates with Mt. Sinai Hospital in New York City and Johns Hopkins in Baltimore to Merge Advanced AI Data Integrations and Interactions Into Its Proprietary Healthcare APP for Instant Multiple Indications and Critical Ailments Professional Analytics
NEW YORK, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Strainsforpains, Inc. fka/ E-Buy Home, Inc. (OTC: EBYH), a leader in the health and wellness sector for 17 years, is proud to announce its collaboration wi...
Strainsforpains (OTC: EBYH) Formally Announces Alliance with the 1-Million Strong Killing Cancers, Fight Club (1MSFC) and the Inaugural Live 1MSFC #1 MMA Fight for 4th Quarter 2024 in Florida! Appoints Former WWE, TV Executive VP, Mr.
NEW YORK, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Strainsforpains, Inc., fka/ E-Buy Home Inc., (OTC: EBYH) an emerging cannabinoid-based retail and wholesale drug commercialization specialist is very please...
Strainsforpains-EBYH, CEO Simon Shainberg Signs Strategic Product Commercialization Agreement with Cannabis Science; Shainberg's 2024 Guidance Projects Strong Revenue Growth For Its Multiplied Cannabinoid Drug Commercialization Pipeline
NEW YORK, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Strainsforpains, Inc., fka/ E-Buy Home Inc., (OTC: EBYH) an emerging cannabinoid-based retail and wholesale drug commercialization specialist is very please...
Strainsforpains, Inc. Investors Update: Strainsforpains, Inc. Showing Strong Revenue Growth
NEW YORK, March 07, 2024 (GLOBE NEWSWIRE) -- -- (E-Buy Homes, Inc. DBA/Strainsforpains, Inc.) (OTC Markets: EBYH) Strainsforpains, Inc. is pleased to announce the successful acquisition of a substanti...
StrainsForPains, Inc. Discusses Inspiration, App Technology and CBD Market Entrance with The Stock Day Podcast
Phoenix, Arizona--(Newsfile Corp. - February 29, 2024) - The Stock Day Podcast welcomed StrainsForPains, Inc. (OTC Pink: EBYH) ("the Company"), a medical marijuana recommendation engine that guides pa...
Strainsforpains Inc. Announces Corporate Update
NEW YORK, Feb. 23, 2024 (GLOBE NEWSWIRE) -- (Strainsforpains, Inc.) (OTC Markets: EBYH). Strainsforpains is pleased to announce that it has increased the capacity of its Pennsylvania facility to accom...
Strainsforpains, Inc. secures its largest orders to date from NYC establishments
NEW YORK, Jan. 19, 2024 (GLOBE NEWSWIRE) -- Strainsforpains, Inc. Announces Corporate Update (Strainsforpains, Inc.) (OTC Markets: EBYH). Strainsforpains, Inc. is pleased to announce it has closed out...